| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 192.34B | 194.75B | 167.03B | 170.63B | 156.77B | 115.13B |
| Gross Profit | 32.01B | 29.85B | 30.44B | 33.10B | 27.77B | 21.60B |
| EBITDA | 10.76B | 16.23B | 11.39B | 10.08B | 6.53B | 7.88B |
| Net Income | 5.58B | 8.96B | 6.36B | 3.83B | 3.14B | 4.30B |
Balance Sheet | ||||||
| Total Assets | 65.28B | 66.35B | 68.46B | 71.63B | 64.11B | 52.67B |
| Cash, Cash Equivalents and Short-Term Investments | 31.00B | 31.71B | 29.32B | 31.97B | 25.83B | 25.27B |
| Total Debt | 12.09B | 7.91B | 12.29B | 16.42B | 19.91B | 11.72B |
| Total Liabilities | 32.58B | 30.02B | 34.01B | 41.70B | 42.87B | 32.47B |
| Stockholders Equity | 31.35B | 34.99B | 33.23B | 28.91B | 20.35B | 19.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.62B | 3.95B | 12.94B | 2.23B | 6.48B |
| Operating Cash Flow | 0.00 | 5.68B | 3.99B | 13.00B | 2.28B | 6.65B |
| Investing Cash Flow | 0.00 | 5.87B | -210.00M | -2.14B | -6.30B | -2.41B |
| Financing Cash Flow | 0.00 | -9.14B | -6.43B | -4.75B | 4.55B | 2.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥246.22B | 16.33 | 28.98% | 5.57% | 4.09% | 17.10% | |
83 Outperform | ¥89.03B | 29.69 | ― | 3.53% | 9.97% | 22.68% | |
79 Outperform | ¥115.79B | 13.47 | ― | 7.51% | 8.28% | -36.32% | |
73 Outperform | ¥9.66T | 21.38 | 27.29% | 0.27% | 1.23% | 26.94% | |
66 Neutral | ¥542.85B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥73.79B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |